Transarterial Chemoembolisation and Combined Therapy

In Hepatocellular carcinoma (HCC), transarterial chemoembolisation (TACE) is the most widely used loco-regional treatment not only in the intermediate stage, but often also in early or advanced disease (“treatment stage migration”), but is the least standardised, both in terms of indications and techniques. The rationale for the efficacy of transarterial therapies is that the vascularisation of HCC is, for the most part, dependent on the hepatic artery.